IL114407A0 - Novel peptides and pharmaceutical compositions comprising them - Google Patents

Novel peptides and pharmaceutical compositions comprising them

Info

Publication number
IL114407A0
IL114407A0 IL11440795A IL11440795A IL114407A0 IL 114407 A0 IL114407 A0 IL 114407A0 IL 11440795 A IL11440795 A IL 11440795A IL 11440795 A IL11440795 A IL 11440795A IL 114407 A0 IL114407 A0 IL 114407A0
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
novel peptides
peptides
novel
pharmaceutical
Prior art date
Application number
IL11440795A
Other languages
English (en)
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Priority to IL11440795A priority Critical patent/IL114407A0/xx
Publication of IL114407A0 publication Critical patent/IL114407A0/xx
Priority to UY24270A priority patent/UY24270A1/es
Priority to CN96196403A priority patent/CN1102598C/zh
Priority to JP1997505319A priority patent/JP3955627B6/ja
Priority to AU64845/96A priority patent/AU710882B2/en
Priority to US08/981,787 priority patent/US6110746A/en
Priority to DE69634438T priority patent/DE69634438T2/de
Priority to ARP960103410A priority patent/AR003446A1/es
Priority to CA2225675A priority patent/CA2225675C/en
Priority to ES96924372T priority patent/ES2239770T3/es
Priority to ZA9605565A priority patent/ZA965565B/xx
Priority to IL12275796A priority patent/IL122757A/en
Priority to DK96924372T priority patent/DK0845943T3/da
Priority to CZ19974117A priority patent/CZ295110B6/cs
Priority to PCT/US1996/011375 priority patent/WO1997001959A1/en
Priority to AT96924372T priority patent/ATE290315T1/de
Priority to EP96924372A priority patent/EP0845943B1/en
Priority to HU9901688A priority patent/HUP9901688A3/hu
Priority to KR1019970709962A priority patent/KR100454554B1/ko
Priority to HR114407A priority patent/HRP960307A2/hr
Priority to NO19976094A priority patent/NO320715B1/no
Priority to MXPA/A/1998/000191A priority patent/MXPA98000191A/xx
Priority to US09/613,743 priority patent/US6682897B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/80—Fluorescent dyes, e.g. rhodamine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/804—Radioisotope, e.g. radioimmunoassay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL11440795A 1995-06-30 1995-06-30 Novel peptides and pharmaceutical compositions comprising them IL114407A0 (en)

Priority Applications (23)

Application Number Priority Date Filing Date Title
IL11440795A IL114407A0 (en) 1995-06-30 1995-06-30 Novel peptides and pharmaceutical compositions comprising them
UY24270A UY24270A1 (es) 1995-06-30 1996-06-28 Nuevos peptidos derivados de la proteína 60 humana por choque térmico para el tratamiento de diabetes, las composiciones, los métodos y equipos.
HR114407A HRP960307A2 (en) 1995-06-30 1996-07-01 Novel peptides derived from human heat shock protein 60 for treatment of diabetes - preparations, methods and kits
ZA9605565A ZA965565B (en) 1995-06-30 1996-07-01 Novel peptides derived from human heat shock protein 60 for treatment of diabetes, compositions, methods and kits.
CZ19974117A CZ295110B6 (cs) 1995-06-30 1996-07-01 Nové peptidy odvozené z lidského proteinu tepelného šoku 60 pro léčbu diabetes mellitus, farmaceutické přípravky, způsoby léčení a diagnostické soupravy
AU64845/96A AU710882B2 (en) 1995-06-30 1996-07-01 Novel peptides derived from human heat shock protein 60 for treatment of diabetes, compositions, methods and kits
US08/981,787 US6110746A (en) 1995-06-30 1996-07-01 Peptides derived from human heat shock protein 60 for treatment of diabetes, compositions, methods and kits
DE69634438T DE69634438T2 (de) 1995-06-30 1996-07-01 Von humanem hitzeschockprotein 60 hergeleitete peptide zur behandlung von diabetis, entsprechende zusammensetzungen, verfahren und kits
ARP960103410A AR003446A1 (es) 1995-06-30 1996-07-01 Peptidos derivados de la proteina 60 humana por shock termico para diagnosis y tratamiento de diabetes, las composiciones farmaceuticas y los metodos para diagnosticar
CA2225675A CA2225675C (en) 1995-06-30 1996-07-01 Novel peptides derived from human heat shock protein 60 for treatment of diabetes, compositions, methods and kits
ES96924372T ES2239770T3 (es) 1995-06-30 1996-07-01 Nuevos peptidos derivados de la proteina humana de choque termico 60 para el tratamiento de diabetes, sus compuestos, metodos y equipos de diagnostico.
CN96196403A CN1102598C (zh) 1995-06-30 1996-07-01 由人热激蛋白60衍生的新型肽类及其组合物和应用
IL12275796A IL122757A (en) 1995-06-30 1996-07-01 Peptides derived from human HEAT SHOCK 60 protein for the treatment of diabetes, preparations, methods and kits
DK96924372T DK0845943T3 (da) 1995-06-30 1996-07-01 Nye peptider afledt fra humant heat shock protein 60 til behandling af diabetes, sammensætninger, fremgangsmåder og kits
JP1997505319A JP3955627B6 (ja) 1995-06-30 1996-07-01 糖尿病の治療のためのヒト熱ショックタンパク質６０由来の新規ペプチド、組成物、方法およびキット
PCT/US1996/011375 WO1997001959A1 (en) 1995-06-30 1996-07-01 Novel peptides derived from human heat shock protein 60 for treatment of diabetes, compositions, methods and kits
AT96924372T ATE290315T1 (de) 1995-06-30 1996-07-01 Von humanem hitzeschockprotein 60 hergeleitete peptide zur behandlung von diabetis, entsprechende zusammensetzungen, verfahren und kits
EP96924372A EP0845943B1 (en) 1995-06-30 1996-07-01 Novel peptides derived from human heat shock protein 60 for treatment of diabetes, compositions, methods and kits
HU9901688A HUP9901688A3 (en) 1995-06-30 1996-07-01 Novel peptides derived from human heat shock protein 60 for treatment of diabetes, compositions, methods and kits
KR1019970709962A KR100454554B1 (ko) 1995-06-30 1996-07-01 당뇨병 치료를 위한 인간의 열쇼크 단백질60 유래의 신규펩티드들, 조성물들, 방법들 및 키트들
NO19976094A NO320715B1 (no) 1995-06-30 1997-12-29 Nye peptider avledet av humant varmesjokkprotein 60, farmasoytiske preparater omfattende slike og anvendelse av de nye peptider for fremstilling av farmasoytiske preparater for behandling og forebyggelse av insulinavhengig diabetes mellitus, samt fremgangsmate og sett for diagnostisering av IDDM.
MXPA/A/1998/000191A MXPA98000191A (en) 1995-06-30 1998-01-07 Novedous peptides derived from human protein 60 produced by thermal shock, for the treatment of diabetes, compositions, methods and equi
US09/613,743 US6682897B1 (en) 1995-06-30 2000-07-11 Peptides derived from human heat protein 60 for treatment of diabetes, compositions, methods and kits

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL11440795A IL114407A0 (en) 1995-06-30 1995-06-30 Novel peptides and pharmaceutical compositions comprising them

Publications (1)

Publication Number Publication Date
IL114407A0 true IL114407A0 (en) 1995-10-31

Family

ID=11067704

Family Applications (2)

Application Number Title Priority Date Filing Date
IL11440795A IL114407A0 (en) 1995-06-30 1995-06-30 Novel peptides and pharmaceutical compositions comprising them
IL12275796A IL122757A (en) 1995-06-30 1996-07-01 Peptides derived from human HEAT SHOCK 60 protein for the treatment of diabetes, preparations, methods and kits

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL12275796A IL122757A (en) 1995-06-30 1996-07-01 Peptides derived from human HEAT SHOCK 60 protein for the treatment of diabetes, preparations, methods and kits

Country Status (19)

Country Link
US (1) US6682897B1 (da)
EP (1) EP0845943B1 (da)
KR (1) KR100454554B1 (da)
CN (1) CN1102598C (da)
AR (1) AR003446A1 (da)
AT (1) ATE290315T1 (da)
AU (1) AU710882B2 (da)
CA (1) CA2225675C (da)
CZ (1) CZ295110B6 (da)
DE (1) DE69634438T2 (da)
DK (1) DK0845943T3 (da)
ES (1) ES2239770T3 (da)
HR (1) HRP960307A2 (da)
HU (1) HUP9901688A3 (da)
IL (2) IL114407A0 (da)
NO (1) NO320715B1 (da)
UY (1) UY24270A1 (da)
WO (1) WO1997001959A1 (da)
ZA (1) ZA965565B (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6488933B2 (en) 1995-07-05 2002-12-03 Yeda Research And Development Co. Ltd. Preparations for the treatment of T cell mediated diseases
DE69724619T2 (de) * 1996-05-14 2004-07-01 Winnacker, Ernst-Ludwig, Prof. Chaperone, die prionproteine binden und zwischen den isoformen prpc und prpsc unterscheiden können
US5993803A (en) * 1996-08-30 1999-11-30 Yeda Research And Development Co., Ltd. Method of reducing the severity of host vs graft reaction by down-regulating hsp60 autoimmunity
CA2394504A1 (en) * 1999-12-15 2001-06-21 Peptor Ltd. Fragments and antagonists of heat shock protein 60
EP1335741A4 (en) * 2000-08-25 2005-10-26 Yeda Res & Dev METHOD FOR THE PREVENTION OF AUTOIMMUNE DISEASES WITH CpG-CONTAINING POLYNUCLEOTIDES (04.03.02)
WO2003063759A2 (en) 2002-01-31 2003-08-07 Peptor Ltd. Hsp peptides and analogs for modulation of immune responses via antigen presenting cells
WO2003070761A1 (en) * 2002-02-19 2003-08-28 Yeda Research And Development Co. Ltd. Dual-effect ligands comprising anti-inflammatory hsp peptide epitopes for immunomodulation
ES2433915T3 (es) 2002-05-21 2013-12-13 Irun R. Cohen Vacunas de ADN que codifican proteínas de choque térmico
WO2004098489A2 (en) * 2003-05-12 2004-11-18 Peptor Ltd. Compositions and methods for modulation of specific epitopes of hsp60
CA2547079A1 (en) * 2003-11-24 2005-06-02 Yeda Research & Development Co. Ltd. Dna vaccines encoding hsp60 peptide fragments for treating autoimmune diseases
CA2595520A1 (en) 2004-01-28 2005-08-11 Develogen Israel Ltd. Hsp therapy in conjunction with a low antigenicity diet
US8691772B2 (en) 2005-01-04 2014-04-08 Yeda Research And Development Co. Ltd. HSP60, HSP60 peptides and T cell vaccines for immunomodulation
CU23701A1 (es) * 2008-12-29 2011-09-21 Ct Ingenieria Genetica Biotech Método de tratamiento de enfermedades inflamatorias intestinales y diabetes tipo i
US9102942B2 (en) 2010-02-04 2015-08-11 EWHA University—Industry Collaboration Foundation Pharmaceutical composition for inhibiting abnormal proliferation of cells
ITCO20120007A1 (it) * 2012-02-21 2013-08-22 Nuovo Pignone Srl Dispositivo di filtraggio dell'aria in ingresso per un impianto
CN104203263A (zh) 2012-03-01 2014-12-10 耶达研究与发展有限公司 利用HSP60衍生肽再生胰岛β细胞
WO2013128450A1 (en) 2012-03-01 2013-09-06 Yeda Research And Development Co. Ltd. Hsp60 derived peptides and peptide analogs for suppression and treatment of non-autoimmune diabetes
JP2019523633A (ja) * 2016-04-29 2019-08-29 アライム ファーマシューティカルズ，インコーポレーテッド 組織の損傷に関連した疾患及び障害を予防及び治療する組織保護ペプチド
CN111035755B (zh) * 2020-01-08 2023-04-14 中国医学科学院医学生物学研究所 一种1型糖尿病疫苗及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242823A (en) * 1986-03-07 1993-09-07 International Genetic Engineering, Inc. Cloning of the 38kd Mycoplasma hyorhinis regression-associated antigen
US4976958A (en) * 1987-02-26 1990-12-11 Scripps Clinic And Research Foundation Mycobacterial recombinants and peptides
US5114844A (en) * 1989-03-14 1992-05-19 Yeda Research And Development Co., Ltd. Diagnosis and treatment of insulin dependent diabetes mellitus

Also Published As

Publication number Publication date
EP0845943B1 (en) 2005-03-09
HUP9901688A2 (hu) 1999-09-28
HUP9901688A3 (en) 1999-12-28
DE69634438D1 (de) 2005-04-14
IL122757A0 (en) 1998-08-16
CN1193889A (zh) 1998-09-23
EP0845943A1 (en) 1998-06-10
DK0845943T3 (da) 2005-07-11
DE69634438T2 (de) 2006-02-09
ATE290315T1 (de) 2005-03-15
AU6484596A (en) 1997-02-05
IL122757A (en) 2001-07-24
CA2225675A1 (en) 1997-01-23
HRP960307A2 (en) 1998-04-30
JP3955627B2 (ja) 2007-08-08
JPH11509196A (ja) 1999-08-17
CZ295110B6 (cs) 2005-05-18
ES2239770T3 (es) 2005-10-01
AU710882B2 (en) 1999-09-30
NO320715B1 (no) 2006-01-23
AR003446A1 (es) 1998-08-05
WO1997001959A1 (en) 1997-01-23
KR19990028640A (ko) 1999-04-15
CA2225675C (en) 2010-09-21
ZA965565B (en) 1997-02-26
US6682897B1 (en) 2004-01-27
EP0845943A4 (en) 2002-04-10
NO976094L (no) 1998-02-02
CN1102598C (zh) 2003-03-05
UY24270A1 (es) 2000-12-29
MX9800191A (es) 1998-05-31
NO976094D0 (no) 1997-12-29
CZ411797A3 (cs) 1998-06-17
KR100454554B1 (ko) 2005-04-06

Similar Documents

Publication Publication Date Title
IL116512A0 (en) Cyclic peptides their preparation and pharmaceutical compositions containing them
IL119078A (en) Substituted benzylaminopiperidine compounds and pharmaceutical compositions comprising them
IL114622A0 (en) Heteroaryl-oxazolidinones and pharmaceutical compositions containing them
IL117349A0 (en) N-(3-benyofuranyl) urea-derivatives their preparation and pharmaceutical compositions containing them
HUP0001309A3 (en) 1-phenyl-4-benzylpiperazines and pharmaceutical compositions containing them
IL114407A0 (en) Novel peptides and pharmaceutical compositions comprising them
IL119316A0 (en) Hydroxypyridinones their preparation and pharmaceutical compositions containing them
IL117554A0 (en) Imidazoquinazolines their preparation and pharmaceutical compositions containing them
ZA967827B (en) Pharmaceutical compositions
ZA967800B (en) Heteroaryllsubstituted acryloylguanidine derivatives and pharmaceutical compositions comprising them
IL114736A0 (en) Peptides theit production and pharmaceutical compositions containing them
EG24294A (en) Pharmaceutical compositions
IL114673A0 (en) Pharmaceutical compositions containing protein
GB9506382D0 (en) Pharmaceutical compositions
GB9513972D0 (en) Pharmaceutical compositions
IL118672A0 (en) Benzisothiazolyl-substituted aminomethylchromans their preparation and pharmaceutical compositions containing them
IL119371A0 (en) Sulfonylaminopyrimidines their preparation and pharmaceutical compositions containing them
HUP0000460A3 (en) Imidazopyridazines and pharmaceutical compositions thereof
AU7000896A (en) Novel peptide compounds and medicinal compositions thereof
ZA96240B (en) Novel peptides their preparation and use
GB9501286D0 (en) Pharmaceutical compositions and preparations thereof
EP0821694A4 (en) CONOTOXIN PEPTIDES
ZA96239B (en) Novel peptides their preparation and use
IL120341A (en) Phenyl peptides their preparation and pharmaceutical compositions containing them
IL112094A0 (en) Novel peptides and pharmaceutical compositions comprising them